NAGESWARA CHUNDURU: Open Payments
NPI 1841360930 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 37 payments from 17 companies in 2025. Trend: 2023 $104 · 2024 $1,187 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $179 |
| Alkermes, Inc. | 1 | $95 |
| Novo Nordisk Inc | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Verona Pharma, Inc. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| PFIZER INC. | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: FANAPT, LYBALVI, Ozempic, Ohtuvayre, FARXIGA, GEMTESA, ZENPEP, PREVNAR 20.
Industry payments across TN — which companies pay providers there.
